HeplerCDStrandLM.Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47(3):533-543. http://www.ncbi.nlm.nih.gov/pubmed/2316538. Accessed April 16, 2019.
2.
BlackburnDFYakiwchukEMJorgensonDJMansellKD.Proposing a redefinition of pharmaceutical care. Ann Pharmacother. 2012;46(3):447-449. doi:10.1345/aph.1Q585.
3.
Morillo VerdugoRSáez de la FuenteJCalleja HernandezMÁ. [MAPEX: look deeper, looking away]. Farm Hosp. 2015;39(4):189-191. doi:10.7399/fh.2015.39.4.9407.
4.
Spanish strategic map for outpatient care of the Spanish Society of Hospital Pharmacist. Date unknown. https://www.sefh.es/mapex/index.php. Accessed July 19, 2019.
5.
Morillo-VerdugoRMartínez-SesmeroJMLázaro-LópezASánchez-RubioJNavarro-AznárezHDeMiguel-CascónM.Development of a risk stratification model for pharmaceutical care in HIV patients. Farm Hosp. 2017;41(3):346-356. doi:10.7399/fh.2017.41.3.10655.
6.
The consensus of the Pharmacy Practice Model Summit. Am J Heal Pharm. 2011;68(12):1148-1152. doi:10.2146/ajhp110060.
7.
WimmerBCBellJSFastbomJWieseMDJohnellK.Medication regimen complexity and polypharmacy as factors associated with all-cause mortality in older people: a population-based cohort study. Ann Pharmacother. 2016;50(2):89-95. doi:10.1177/1060028015621071.
8.
MillerWRolnickS. Motivational Interviewing: Preparing People for Change. 2nd ed.New York, 2002.
9.
Morillo-VerdugoRRobustillo-CortésMAManzano GarcíaMAlmeida-GonzálezCV.Influence of pharmacist intervention, based on CMO model, to improve activation in HIV patients. Rev Esp Quimioter. 2019;32(1):40-49. http://www.ncbi.nlm.nih.gov/pubmed/30569694. Accessed April 16, 2019.
10.
AlexanderEButlerCDDarrA, et al. ASHP statement on telepharmacy. Am J Health Syst Pharm. 2017;74(9):e236-e241. doi:10.2146/ajhp170039.
Margusino-FramiñánLCid-SilvaPMartínez-RocaC, et al. Implementation of specialized pharmaceutical care hospital outpatient clinics in a hospital pharmacy department. Farm Hosp. 2017;41(6):660-666. doi:10.7399/fh.10771.
13.
Morillo-VerdugoRRobustillo-CortésMdeLAMartín-CondeMT, et al. Effect of a structured pharmaceutical care intervention versus usual care on cardiovascular risk in HIV patients on antiretroviral therapy: INFAMERICA study. Ann Pharmacother. 2018;52(11):1098-1108. doi:10.1177/1060028018778045.
14.
Cantillana-SuárezMdeGManzano-GarcíaMRobustillo-CortésMdeLAMorillo-VerdugoR.Evaluation of HIV+ patients experience with pharmaceutical care based on AMO-methodology. Farm Hosp. 2018;42(5):200-203. doi:10.7399/fh.10947.
15.
Morillo VerdugoRVillarreal ArevaloALAlvarezDeSotomayorMRobustillo CortesMdeLA.Development of a taxonomy for pharmaceutical interventions in HIV+ patients based on the CMO model. Farm Hosp. 2016;40(6):544-568. doi:10.7399/fh.2016.40.6.10567.